Cytokine production and antitumor effect of a nonreplicating, noncytopathic recombinant vaccinia virus expressing interleukin-12

Surgery

Volumn 120, Issue 2, 1996, Pages 274-283

  Meko, J B ^a   Tsung, K ^a   Norton, J A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE THERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS RECOMBINANT;

EID: 0029823656     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(96)80298-4     Document Type: Article

References (22)

1. Gubler U Chua AO Schoenhout DS Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor Proc Natl Acad Sci USA 88 1991 4143 4147
2. Zeh HJ Hurd S Storkus WJ Lotze MT Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer J Immunotherapy 14 1993 155 161
3. Gately MK Warrier RR Honasoge S Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-ψ in vivo Int Immunol 6 1994 157 167
4. Nastala CL Edington HD McKinney TG Recombinant IL-12 administration induces tumor regression in association with IFN-ψ production J Immunol 153 1994 1697 1706
5. McKnight AJ Zimmer GJ Fogelman I Wolf SF Abbas AK Effects of IL-12 on helper T cell-dependent immune responses in vivo J Immunol 152 1994 2172 2179
6. Wong HI Wilson DE Jenson JC Familletti PC Stremlo DL Gately MK Characterization of a factor(s) which synergizes with recombinant interleukin 2 in promoting allogeneic human cytolytic T-lymphocyte responses in vitro Cell Immunol 111 1988 39 54
7. Scott P IL-12: initiation cytokine for cell-mediated immunity Science 260 1993 496 497
8. Brunda MJ Luistro I Warrier RR Antitumor and antimetastatic activity of interleukin 12 against murine tumors J Exp Med 178 1993 1223 1230
9. Mu J Zou J-P Yamamoto N Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes Cancer Res 55 1995 4404 4408
10. Tahara H Zeh HJ Storkus WJ Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo Cancer Res 54 1994 182 189
11. Tahara H Zitvogel L Storkus WJ Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector J Immunol 154 1995 6466 6474
12. Jolly D Viral vector systems for gene therapy Cancer Gene Ther 1 1994 51 64
13. Meko JB Yim JH Tsung K Norton JA High cytokine production and effective antitumor activity of a recombinant vaccinia virus encoding murine interleukin 12 Cancer Res 55 1995 4765 4770
14. 15.1-16.18.10 Earl PL Moss B Protein expression IV: expression of proteins in mammalian cells using vaccinia Ausubel FM Brent R Kingston RE Current protocols in molecular biology 1991 Greene Publishing Associates and Wiley-Interscience New York
15. Tsung K Yim JH Marti W Buller RML Norton JA Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light J Virol 70 1996 165 171
16. Venkatesan S Baroudy BM Moss B Distinctive nucleotide sequences adjacent to multiple initiation and termination sites of an early vaccinia virus gene Cell 125 1981 805 813
17. Sutter G Wyatt LS Foley PL Bennink JR Moss B A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus Vaccine 12 1994 1032 1040
18. Seki M Oie M Ichihashi Y Shida H Hemadsorption and fusion inhibition activities of hemagglutinin analyzed by vaccinia virus mutants Virology 175 1990 372 384
19. Mattner F Fischer S Guckes S The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer Eur J Immunol 23 1993 2202 2208
20. Flexner C Hugin A Moss B Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression Nature 330 1987 259 262
21. Hanson CV Photochemical inactivation of viruses with psoralens: an overview Blood Cells 18 1992 7 25
22. Restifo NP Esquivel F Asher AL Defective presentation of endogenous antigens by a murine sarcoma: implications for the failure of an anti-tumor immune response J Immunol 147 1991 1453 1459